[1] |
陈新, 徐文华, 周健, 等. 口腔鳞状细胞癌现状[J]. 口腔医学, 2017, 37(5): 462-465.
|
|
Chen X, Xu WH, Zhou J, et al.Current situation of oral squa-mous cell carcinoma[J]. Stomatology, 2017, 37(5): 462-465.
|
[2] |
Moore SR, Johnson NW, Pierce AM, et al.The epidemio-logy of mouth cancer: a review of global incidence[J]. Oral Dis, 2000, 6(2): 65-74.
|
[3] |
Riemann M, Knipfer C, Rohde M, et al.Oral squamous cell carcinoma of the tongue: prospective and objective speech evaluation of patients undergoing surgical therapy[J]. Head Neck, 2016, 38(7): 993-1001.
|
[4] |
Chang CC, Yang YJ, Li YJ, et al.MicroRNA-17/20a func-tions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma[J]. Oral Oncol, 2013, 49(9): 923-931.
|
[5] |
Kaneda MM, Caruthers S, Lanza GM, et al.Perfluorocarbon nanoemulsions for quantitative molecular imaging and tar-geted therapeutics[J]. Ann Biomed Eng, 2009, 37(10): 1922-1933.
|
[6] |
Rapoport N, Christensen DA, Kennedy AM, et al.Cavitation properties of block copolymer stabilized phase-shift nanoe-mulsions used as drug carriers[J]. Ultrasound Med Biol, 2010, 36(3): 419-429.
|
[7] |
徐芬芬, 王志刚, 李攀, 等. 载10-羟基喜树碱液态氟碳纳米粒制备及其表征、体外增强超声显像效果观察[J]. 中国医学影像技术, 2014, 30(8): 1127-1130.
|
|
Xu FF, Wang ZG, Li P, et al.Preparation of 10-HCPT loaded perfluoropentane nanoparticles and observation its characte-ristic, enhancement effect for ultrasound imaging in vitro[J]. Chin J Med Imaging Technol, 2014, 30(8): 1127-1130.
|
[8] |
刘建新, 尚婷婷, 徐芬芬, 等. 叶酸靶向液态氟碳脂质纳米粒的制备及其超声分子显像卵巢癌实验[J]. 中国医学影像技术, 2016, 32(12): 1843-1847.
|
|
Liu JX, Shang TT, Xu FF, et al.Preparation of folic acid targeted liquid fluorocarbon lipid nanoparticles and appli-cation in ultrasound molecular imaging of ovarian cancer[J]. Chin J Med Imaging Technol, 2016, 32(12): 1843-1847.
|
[9] |
Lowe KC.Engineering blood: synthetic substitutes from fluorinated compounds[J]. Tissue Eng, 2003, 9(3): 389-399.
|
[10] |
Zheng C, Zheng M, Gong P, et al.Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging[J]. Biomaterials, 2012, 33(22): 5603-5609.
|
[11] |
Jori G, Spikes JD.Photothermal sensitizers: possible use in tumor therapy[J]. J Photochem Photobiol B, 1990, 6(1/2): 93-101.
|
[12] |
Jain RA.The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices[J]. Biomaterials, 2000, 21(23): 2475-2490.
|
[13] |
Delilbasi CB, Okura M, Iida S, et al.Investigation of CXCR4 in squamous cell carcinoma of the tongue[J]. Oral Oncol, 2004, 40(2): 154-157.
|
[14] |
张骁, 束梅英, 张韬. 多西紫杉醇用于癌症治疗的临床研究进展[J]. 中国制药信息, 2005, 21(12): 3-9.
|
|
Zhang X, Su MY, Zhang T.Clinical research progress of docetaxel for cancer treatment[J]. Chin Pharma Inf, 2005, 21(12): 3-9.
|
[15] |
Li J, Feng L, Fan L, et al.Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides[J]. Biomaterials, 2011, 32(21): 4943-4950.
|
[16] |
Lu W, Zhang Y, Tan YZ, et al.Cationic albumin-conjugated pegylated nanoparticles as novel Drug carrier for brain deli-very[J]. J Control Release, 2005, 107(3): 428-448.
|
[17] |
Habash RW, Bansal R, Krewski D, et al.Thermal therapy, part 1: an introduction to thermal therapy[J]. Crit Rev Bio-med Eng, 2006, 34(6): 459-489.
|
[18] |
Campbell RB.Tumor physiology and delivery of nanophar-maceuticals[J]. Anticancer Agents Med Chem, 2006, 6(6): 503-512.
|
[19] |
Iyer AK, Khaled G, Fang J, et al.Exploiting the enhanced permeability and retention effect for tumor targeting[J]. Drug Discov Today, 2006, 11(17/18): 812-818.
|
[20] |
Mu X, Zhang F, Kong C, et al.EGFR-targeted delivery of DOX-loaded Fe3O4 polydopamine multifunctional nano-composites for MRI and antitumor chemo-photothermal therapy[J]. Int J Nanomedicine, 2017, 12: 2899-2911.
|
[21] |
Nguyen HT, Phung CD, Thapa RK, et al.Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy[J]. Acta Biomater, 2018, 68: 154-167.
|
[22] |
张晓燕, 平其能. 多西紫杉醇白蛋白纳米粒的制备及体外评价[J]. 药学进展, 2008, 32(5): 223-228.
|
|
Zhang XY, Ping QN.Preparation and in vitro evaluation of bovine serum albumin nanoparticles containing docetaxel[J]. Progress Pharma Sci, 2008, 32(5): 223-228.
|
[23] |
Meng W, Xue S, Chen Y.The role of CXCL12 in tumor microenvironment[J]. Gene, 2018, 641: 105-110.
|
[24] |
Chittasupho C, Lirdprapamongkol K, Kewsuwan P, et al.Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles[J]. Eur J Pharm Biopharm, 2014, 88(2): 529-538.
|
[25] |
Mei L, Liu Y, Zhang Q, et al.Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin[J]. J Control Release, 2014, 196: 324-331.
|
[26] |
Janssens R, Struyf S, Proost P.The unique structural and functional features of CXCL12[J]. Cell Mol Immunol, 2017. doi: 10.1038/cmi.2017.107.
|
[27] |
Li X, Qin F, Yang L, et al.Sulfatide-containing lipid per-fluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma[J]. Int J Nanomedicine, 2014, 9: 3971-3985.
|